CA2476008C — Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2011-12-13 · 14y expired
What this patent protects
The present invention relates to bicyclic heterocyclic groups of general formula (see formula I) wherein R a, R b, R c, R d and X are defined as in claim 1, the tautomers, the stereoisomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts the…
USPTO Abstract
The present invention relates to bicyclic heterocyclic groups of general formula (see formula I) wherein R a, R b, R c, R d and X are defined as in claim 1, the tautomers, the stereoisomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with inorganic or organic acids which have valuable pharmacological properties, particularly an inhibitory effect on signal transduction mediated by tyrosine kinases, the use thereof for treating diseases, particularly tumoral diseases, as well as benign prostate hyperplasia (BPH), diseases of the lungs and respiratory tract, and the preparation thereof.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.